Technology Assisted Treatment for Trichotillomania
Primary Purpose
Trichotillomania
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Device and app system designed for participant to self-administer Habit Reversal Training and Stimulus Control
Reminder bracelet and journaling app control condition
Sponsored by
About this trial
This is an interventional treatment trial for Trichotillomania focused on measuring Hair Pulling Disorder, Body-Focused Repetitive Behaviors, Trichotillomania
Eligibility Criteria
Inclusion Criteria:
- Willingness to participate;
- Current diagnosis of TTM (as assessed via TDI);
- Regular access to a smartphone with GPS capabilities (i.e., available for completing assessment probes throughout the day);
Exclusion Criteria:
- Currently receiving psychotherapy
- Other psychiatric condition requiring more immediate care
- Have previously used any behavior awareness devices (e.g. Keen)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Experimental group - HabitAware condition
Control group - reminder bracelet condition
Arm Description
This group will receive the device which alerts the participant when performing hair pulling behavior and the app which provides psychoeducation and components of Habit Reversal Training.
This group will receive only a device that vibrates randomly several times per hour as a reminder not to pull, as well as being asked to journal about their daily activities in an app.
Outcomes
Primary Outcome Measures
Improvement in clinical symptoms amongst participants
Demonstrated improvement in clinical symptoms on the MGH-HPS and/or NIMH-TSS for those in the HabitAware condition.
Secondary Outcome Measures
Full Information
NCT ID
NCT05118633
First Posted
November 2, 2021
Last Updated
February 28, 2023
Sponsor
HabitAware Inc.
Collaborators
Kent State University
1. Study Identification
Unique Protocol Identification Number
NCT05118633
Brief Title
Technology Assisted Treatment for Trichotillomania
Official Title
Technology Assisted Treatment for Trichotillomania
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 2024 (Anticipated)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
HabitAware Inc.
Collaborators
Kent State University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Trichotillomania is characterized by recurrent hair pulling resulting in hair loss causing significant distress and impairment which persists despite repeated attempts to stop. Behavioral based therapies focused on increasing awareness of hair pulling followed by the use of an incompatible behavior have proven effective. In an effort to enhance awareness, a wrist worn motion detection device and a companion mobile application was created. In this study, we will test the initial efficacy of the HabitAware device and accompanying app as a system for delivering self-administered habit reversal training (HRT).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trichotillomania
Keywords
Hair Pulling Disorder, Body-Focused Repetitive Behaviors, Trichotillomania
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Experimental group - HabitAware condition
Arm Type
Experimental
Arm Description
This group will receive the device which alerts the participant when performing hair pulling behavior and the app which provides psychoeducation and components of Habit Reversal Training.
Arm Title
Control group - reminder bracelet condition
Arm Type
Placebo Comparator
Arm Description
This group will receive only a device that vibrates randomly several times per hour as a reminder not to pull, as well as being asked to journal about their daily activities in an app.
Intervention Type
Behavioral
Intervention Name(s)
Device and app system designed for participant to self-administer Habit Reversal Training and Stimulus Control
Intervention Description
Participants will receive an awareness bracelet and an app that work together to implement key features of Habit Reversal Training and Stimulus Control. The participant will take part in psychoeducation, awareness training, and competing response training related to trichotillomania, as well as receive stimulus control reminders.
Intervention Type
Behavioral
Intervention Name(s)
Reminder bracelet and journaling app control condition
Intervention Description
Participants will receive a bracelet programmed to vibrate randomly several times per hour during waking hours. They will be instructed this is a reminder not to pull. They will also be instructed to journal in an app on their phone several times per day.
Primary Outcome Measure Information:
Title
Improvement in clinical symptoms amongst participants
Description
Demonstrated improvement in clinical symptoms on the MGH-HPS and/or NIMH-TSS for those in the HabitAware condition.
Time Frame
Eight weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Willingness to participate;
Current diagnosis of TTM (as assessed via TDI);
Regular access to a smartphone with GPS capabilities (i.e., available for completing assessment probes throughout the day);
Exclusion Criteria:
Currently receiving psychotherapy
Other psychiatric condition requiring more immediate care
Have previously used any behavior awareness devices (e.g. Keen)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sameer Kumar, BS
Phone
248-990-4720
Email
sameer@habitaware.com
12. IPD Sharing Statement
Learn more about this trial
Technology Assisted Treatment for Trichotillomania
We'll reach out to this number within 24 hrs